Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	28.36	34.81	29.43	39.14	43.84
Short-Term Investments	696.93	388.78	275.52	369.11	150.59
Cash & Short-Term Investments	725.28	423.6	304.95	408.25	194.42
Cash Growth	71.22%	38.91%	-25.30%	109.98%	201.98%
Receivables	0.7	2.63	0.35	0.17	1.8
Prepaid Expenses	21.18	5.47	12.39	2.42	1.62
Total Current Assets	747.16	431.69	317.69	410.84	197.84
Property, Plant & Equipment	8.24	6.64	7.75	6.52	7.26
Other Intangible Assets	27.19	27.19	27.19	27.19	30.69
Other Long-Term Assets	9.75	0.11	0.1	0.1	0.04
Total Assets	792.34	465.63	352.74	444.65	235.84
Accounts Payable	3.27	3.49	3.34	1.23	1.05
Accrued Expenses	33.84	22.03	12.84	12	8.46
Current Portion of Leases	1.45	1.61	1.45	1.75	1.33
Current Unearned Revenue	0.01	3.06	0.06	0.43	-
Other Current Liabilities	0.93	0.93	0.93	1.12	3.37
Total Current Liabilities	39.5	31.13	18.61	16.53	14.21
Long-Term Leases	2.36	0.93	2.59	1.3	2.15
Other Long-Term Liabilities	3.47	4.4	5.33	7.35	10.12
Total Liabilities	45.34	36.46	26.53	25.18	26.48
Common Stock	0.07	0.06	0.05	0.05	0.04
Additional Paid-In Capital	2,299	1,823	1,581	1,561	1,280
Retained Earnings	-1,555	-1,397	-1,256	-1,144	-1,073
Comprehensive Income & Other	3.31	3.31	1.26	1.89	2.59
Shareholders' Equity	747.01	429.17	326.2	419.48	209.36
Total Liabilities & Equity	792.34	465.63	352.74	444.65	235.84
Total Debt	3.81	2.54	4.03	3.04	3.48
Net Cash (Debt)	721.47	421.06	300.92	405.21	190.94
Net Cash Growth	71.35%	39.92%	-25.74%	112.22%	214.43%
Net Cash Per Share	11.20	8.69	6.42	9.45	6.44
Filing Date Shares Outstanding	66.38	55.9	47.21	46.74	39.61
Total Common Shares Outstanding	66.37	55.88	47.2	46.73	39.6
Working Capital	707.66	400.57	299.08	394.31	183.64
Book Value Per Share	11.25	7.68	6.91	8.98	5.29
Tangible Book Value	719.82	401.98	299.01	392.29	178.67
Tangible Book Value Per Share	10.84	7.19	6.33	8.39	4.51
Machinery	17.39	16.01	15.26	14.51	14.61
Construction In Progress	0.14	0.79	0.5	0.63	0.34
Leasehold Improvements	10.29	9.65	9.61	9.53	10.1

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q